Trade shows and events focused on the industry’s hot-button topics, technologies and trends.
Author - simom
3 marketing tips for biotechs emerging from stealth
In a crowded biotech market, here’s how your company can stand out to investors.
FDA’s ‘ivory tower thinking’ ignores promising biomarkers...
The FDA wouldn’t review a drug that was 90% effective. In rare diseases, this is too common, said...
Drugmakers face uphill battle in Medicare negotiation suits
Judges have found fault with drug manufacturers’ First and Fifth Amendment arguments against the...
The PharmaVoice 100: Brand and commercialization pros
Leaders decoding the complex language of drug development to push treatments past the finish line...
Where have all the unicorns gone? A look at 4 billion-dollar...
Not every unicorn company lives up to its $1 billion promise. Here are four worth watching.
5 FDA decisions to watch in the fourth quarter
The regulator is considering approval of what would be the first CRISPR medicine, as well as...
The ALS therapy keeping the human pig heart transplant pumping
Eledon’s investigational ALS drug tegoprubart could also help prevent organ transplant...
The PharmaVoice 100: Cancer care visionaries
Leaders shaping the future of oncology and cancer care through grit and determination in the face...
3 recent FDA adcomm rejections — and why they matter
Decisions that could spell doom for drugs in development and already on the shelves.